Effects of Aralia continentalis root extract on cell proliferation and apoptosis in human promyelocytic leukemia HL-60 cells

Journal of Microbiology and Biotechnology

Volumn 16, Issue 9, 2006, Pages 1399-1404

  Lim, Haeyoung ^a   Oh, Ha Lim ^a   Lee, Chul Hoon ^a  

^a Hanyang University   (South Korea)

Author keywords

Apoptosis; Aralia continentalis; Cell growth inhibition; Dokwhal

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTINEOPLASTIC AGENT; ARALIA CONTINENTALIS EXTRACT; CASPASE 3; METHANOL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT MEDICINAL PRODUCT; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARALIA; ARALIA CONTINENTALIS; ARTICLE; CANCER INHIBITION; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; NICK END LABELING; PLANT ROOT; WESTERN BLOTTING;

ARALIA CONTINENTALIS;

EID: 33750188908     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brown, J. M. and B. G. Wouters. 1999. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59: 1391-1399.
2. Coleman, M. L., E. A. Sahai, M. Yeo, M. Bosch, A. Dewar, and M. F. Olson. 2001. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3: 339-345.
3. Dantzer, F., V. Schreiber, C. Niedergang, C. Trucco, E. Flatter, G. De La Rubia, J. Oliver, V. Rolli, J. Ménissier-de Murcia, and G. de Murcia. 1999. Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie 81: 69-75.
4. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
5. Han, B. H., Y. N. Han, K. A. Han, M. H. Park, and E. O. Lee. 1983. Studies on the anti-inflammatory activity of Aralia continentalis (I). Arch. Pharm. Res. 6: 17-23.
6. Han, B. H., E. R. Woo, M. H. Park, and Y. N. Han. 1985. Studies on the anti-inflammatory activity of Aralia continentalis (III). Arch. Pharm. Res. 8: 59-65.
7. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407: 770-776.
8. Kaufman, S. H. 1989. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 49: 5870-5878.
9. Kaufman, S. H. and W. C. Earnshaw. 2000. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256: 42-49.
10. Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: A basic biological phenomenon with wide-ranging implication in tissue kinetics. Brit. J. Cancer 26: 239-257.
11. Kim, M., C. Shin, H. Yang, S. Kim, H. Lim, C.-H. Lee, M. Kim, and Y. Lim. 2004. Naltriben analogues as peptide anticancer drugs. J. Microbiol. Biotechnol. 14: 881-884.
12. Lee, C.-H., H. Lim, M. Kim, Y. Cho, D. Oh, C. Kim, and Y. Lim. 2002. Isolation and biological properties of novel cell cycle inhibitor, HY558, isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 12: 470-475.
13. Lee, H.-K., I.-H. Lee, J.-S. Yim, Y.-H. Kim, S.-H. Lee, K.-S. Lee, Y.-M. Koo, S.-J. Kim, and B.-C. Jeong. 2005. Purification and characterization of CDMHK, a growth inhibitory molecule against cancer cell lines, from Myxobacterium sp. HK1 isolated from Korean soil. J. Microbiol. Biotechnol. 15: 734-739.
14. Lim, H., M. Kim, Y. Cho, J. Kim, Y. Lim, and C.-H. Lee. 2004. Inhibition of cell cycle progression and induction of apoptosis in HeLa cells by HY558-1, a novel CDK inhibitor isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 14: 978-984.
15. Lim, H., M. Kim, Y. Lim, Y. Cho, and C.-H. Lee. 2006. Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata. Cancer Lett. 233: 89-97.
16. Lim, T. Y. 1987. Comparative study on the pharmacological effect of kinds of Dokhwal. J. Kor. Orient. Med. 8: 97-98.
17. Los, M., C. J. Burek, C. Strol, K. Bnedyk, H. Hug, and A. Mackiewicz. 2003. Anticancer drugs of tomorrow: Apoptotic pathways as targets for drug design. Drug Discov. Today 8: 67-77.
18. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
19. Nunez, G., M. A. Benedict, Y. Hu, and N. Inohara. 1998. Caspases: The proteases of the apoptotic pathway. Oncogene 17: 3237-3245.
20. Reed, J. C. 2001. Apoptosis regulatory proteins as targets for drug discovery. Trends Mol. Med. 7: 314-318.
21. Sahara, S., M. Aoto, Y. Eguchi, N. Imamoto, Y. Yoneda, and Y. Tsujimoto. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401: 168-173.
22. Sebbagh, M., C. Renvoize, J. Hamelin, N. Riche, J. Bertoglio, and J. Breard. 2001. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3: 346-352.
23. Sub, N., L. Luyengi, H. H. Fong, A. D. Kinghorn, and J. M. Pezzuto. 1995. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res. 15: 233-239.
24. Studzinski, G. P. 1999. An overview of apoptosis. In G. P. Studzinski (ed.), Apoptosis: A Practical Approach. Oxford University Press, Oxford, U.K.